RT Article
T1 Introducing the Brave New Crispr World
JF Zygon
VO 55
IS 2
SP 421
OP 429
A1 Gouw, Arvin ca. 20./21. Jh.
LA English
PB Wiley-Blackwell
YR 2020
UL https://www.ixtheo.de/Record/1703031733
AB Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) has been the buzzword for genome editing in the past few years, especially with the birth of Lulu and Nana, twin girls who were genetically edited using the CRISPR/Cas system. To discuss this, a group of scientists, theologians, and ethicists gathered at the 2019 Institute on Religion in the Age of Science (IRAS) conference to discuss the implications of CRISPR gene editing. It became quickly apparent through our discussions that this CRISPR revolution will impact not only human medicine, but any application that involves DNA in every organism from bacteria to plants and animals. Moreover, there are multiple stakeholders in this technology—not only the scientific community, but also the business, legal, and religious communities, to name a few. As a scientist myself, I am providing a brief overview of the scientific hopes and concerns about this powerful technology.
K1 CRISPR
K1 Bioethics
K1 Genetics
DO 10.1111/zygo.12594